DGAP-News: MediClin AG / Key word(s): Preliminary Results
MediClin AG: Sales increased by 1.3 % - Result below previous year's
level
02.03.2012 / 09:01
---------------------------------------------------------------------
Offenburg, 2. März 2012 - In the financial year 2011 MEDICLIN
Aktiengesellschaft (MediClin) has achieved Group sales of EUR 493.6 million
(2010: EUR 487,2 million). The preliminary Group-EBIT amounted to EUR 10.9
million thus EUR 6.0 million below the previous year's value. The
preliminary comprehensive income attributable to shareholders of MediClin
AG was EUR 3.0 million (2010: EUR 10.0 million).
In 2011 a total number of 2.5 million nursing days were provided and more
than 119 thousand cases were treated. With 84.8 % the occupancy rate of the
Group was on a high level, nevertheless did not accomplish the previous
year's value (2010: 86.6%).
Sales increase in the segments and in the business area nursing care
EUR 6.4 million was the increase in sales and EUR 4.1 million are
attributable to the post-acute segment, EUR 0,6 million to the acute
segment and EUR 0.8 million to the business area nursing care. The result
of the post-acute segment decreased from EUR 6.2 million to EUR 2.8 million
due to lower occupancy rates compared to last year and at the same time
higher costs. The result of the acute segment decreased by EUR 2.6 million
to EUR 15.5 million particularly due to higher costs in the reporting year.
Material costs rose slightly by EUR 0.1 million or 0.1% - the material cost
quota declined to 22.4% (2010: 22.6%) as a result of increased sales.
Personnel costs increased by EUR 11.6 million or 4.3% - the personnel cost
quota was 56.5% (2010: 54.8%). The number of staff accounted in full time
employees increased on average by 115 employees and amounted to 6,099
full-time employees on average in 2011 (2010: 5,984 full-time employees).
Other operational expenses stayed the same (2011: EUR 89.3 million; 2010:
EUR 89.3 million). Investments (gross additions to property, plant and
equipment) amounted to EUR 29.9 million EUR (2010: EUR 23.3 million). The
cash flow from operating activities was EUR 15.6 million (2010: EUR 13.4
million).
Change in the Supervisory Board
Dr. Hans Rossels, Managing Director of Kreiskrankenhaus Mechernich, and
President of Krankenhausgesellschaft Nordrhein-Westfalen, resigned on his
own request from the Supervisory Board as of December 31, 2011. Dipl.-Kfm.
Stephan Leonhard, executive director of Asklepios Kliniken GmbH and vice
chairman of corporate management of the Asklepios Group is member of the
Supervisory Board of MediClin AG appointed
by the court as from January 1, 2012.
Credit to the financial result in 2012
Mid of February 2012 loans in the amount of in total EUR 61.4 million from
insurance companies of which two are shareholders of MediClin AG were paid
back. As follow-up financing a syndicated loan in the amount of EUR 50.0
million was taken out. The loan includes a redeemable loan of EUR 45.0
million and a credit line of further EUR 5.0 million in form of a revolving
credit which can be used if required. The package loan contains an option
to increase the redeemable loan and the credit line in each case by further
EUR 5.0 million.
The balance press conference and the analyst conference will take place on
March 22, 2011 in Frankfurt. As from that date the Annual Report 2011 will
be available at www.mediclin.de.
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neurosciences as well as Orthopaedic. With 34
clinics and 7 nursing care facilities and 11 Medizinische
Versorgungszentren (medical care units) in 11 federal states MediClin has a
total capacity of approximately 8,000 beds. MediClins' facilities include
acute care clinics, i.e., general hospitals, special treatment facilities,
specialised hospitals and clinics for post-acute treatment and medical
rehabilitation. MediClin has approximately 8,300 employees.
End of Corporate News
---------------------------------------------------------------------
02.03.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: MediClin AG
OkenstraÃe 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-189
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
159090 02.03.2012
DGAP-News: MediClin AG: Sales increased by 1.3 % - Result below previous year's level
| Quelle: EQS Group AG